+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Mental Illness Drugs Markets in China - Product Thumbnail Image

Mental Illness Drugs Markets in China

  • Report
  • March 2025
  • 251 Pages
  • China
From
Incretion Drugs Markets in China - Product Thumbnail Image

Incretion Drugs Markets in China

  • Report
  • March 2025
  • 247 Pages
  • China
From
Alzheimer Disease Drugs Markets in China - Product Thumbnail Image

Alzheimer Disease Drugs Markets in China

  • Report
  • March 2025
  • 239 Pages
  • China
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • March 2025
  • 215 Pages
  • China
From
Osteoporosis Drugs Markets in China - Product Thumbnail Image

Osteoporosis Drugs Markets in China

  • Report
  • March 2025
  • 205 Pages
  • China
From
Anti-Obesity Drugs Markets in China - Product Thumbnail Image

Anti-Obesity Drugs Markets in China

  • Report
  • March 2025
  • 211 Pages
  • China
From
Central Nervous System Disorder Drugs Markets in China - Product Thumbnail Image

Central Nervous System Disorder Drugs Markets in China

  • Report
  • March 2025
  • 214 Pages
  • China
From
Pneumonia Treatment Drugs Markets in China - Product Thumbnail Image

Pneumonia Treatment Drugs Markets in China

  • Report
  • March 2025
  • 242 Pages
  • China
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more